ICR video toggle

Published: 12 January 2021

  • Views:

    Views Icon 98

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

The Advancements in Atrial Fibrillation Detection and Treatment symposium brings together leading experts in the field of cardiology and electrophysiology to discuss topics including:

  • Atrial fibrillation (AF) detection tools and associated evidence: selecting the right device for each patient
  • How the latest AF detection devices can impact clinical practice
  • AF detection and treatment guidelines
  • The risk-benefit threshold of AF ablation compared to antiarrhythmic drug therapy
  • Who should be referred for an AF ablation
  • AF progression and the associated clinical impact
  • The benefits associated with early AF treatment and first-line ablation

Faculty: Prof. Thorsten Lewalter, Prof. Helmut Pürerfellner, and Prof. Carina Blomström-Lundqvist

This educational content is supported by Medtronic.

Learning objectives

  • AF detection tools that are best suited for different patients and how they can impact clinical practice
  • AF detection and treatment guidelines
  • Who should be referred for an AF ablation and what outcomes they can expect?
  • AF progression and the benefits of early treatment

Target Audience

  • The presentation recordings primarily target cardiologists. General practitioners, allied health professionals, and electrophysiologists may also benefit from this content.

More from this programme

Part 1

El futuro del manejo de la hipertensión: la denervación renal brinda otra opción de tratamiento

2 sessions
El futuro del manejo de la hipertensión: la denervación renal brinda otra opción de tratamiento Watch now
Test video Watch now

Part 2

Die Zukunft des Hypertoniemanagements – Renale Denervierung bietet eine weitere Behandlungsoption

1 session
Die Zukunft des Hypertoniemanagements – Renale Denervierung bietet eine weitere Behandlungsoption Watch now

Part 3

The Future of Hypertension Management - Renal Denervation Provides Another Treatment Option

1 session
The Future of Hypertension Management - Renal Denervation Provides Another Treatment Option Watch now

Part 4

The Science of Renal Denervation

1 session
The Science of Renal Denervation Watch now

Part 5

The science of renal denervation - Part 1

1 session
The science of renal denervation - Part 1 Watch now

Part 6

Can Renal Denervation Benefit Patients with Hypertension?

1 session
Can Renal Denervation Benefit Patients with Hypertension? Watch now

Part 7

TCT 2019: RF renal denervation - Prof Andrew Sharp

1 session
TCT 2019: RF renal denervation - Prof Andrew Sharp Watch now

Faculty Biographies

Andrew SP Sharp

Andrew SP Sharp

Consultant Cardiologist

Prof Andrew Sharp qualified from Edinburgh Medical School in 1998. He conducted his senior clinical training at Imperial College Hospitals and San Raffaele Hospital, Milan, before being appointed in 2011 as a Consultant Cardiologist and Honorary Senior Lecturer at the Royal Devon and Exeter Hospital and University of Exeter. Professor Sharp was awarded an MD postgraduate research degree for his work on the hypertensive heart whilst at Imperial College and now leads a growing research programme at the Royal Devon and Exeter Hospital in the fields of hypertension, renal denervation, ischaemic heart disease, intra-coronary imaging, coronary physiology, pulmonary embolus and aortic valve disease.

View full profile

Comments

You must be to comment. If you are not registered, you can register here.